Dynamicpro-Technology-Management near Ritchot MB (623 Result(s))

In the modern world, the pace of development is accelerating. The demand for electrical power is growing rapidly as countries around the world develop and strive to improve their standard of living. The rising cost of power also means that developing nati

Scootaround is the nation's leading mobility enhancement company providing scooter and wheelchair rentals in over 1500 locations throughout North America. Customers can arrange worry-free rentals through a 7-day toll-free number or via a full-featured Internet website. Scootaround has developed a network of associates throughout North America to meet the most diverse travel needs from conventions and business travel to vacations and cruises. More recently, Scootaround services have extended to contracts with the major airlines in the servicing and repair of passenger mobility equipment that has been damaged in transit. With its growing network, Scootaround continues to meet the most diverse travel needs from vacations and business travel to cruises and conventions.Our Mission'To be the provider of mobility services for traveling customers worldwide'In today's population, there are a growing number of people that rely on electric scooters and related equipment to remain mobile in everyday life; the busy conference attendee who needs to navigate a large convention center, cruise goers who want the independence and safety that these devices provide, the elderly and those with physically challenges who simply need extra assistance in their daily lives

Slo-Pitch National Softball Inc., commonly known as Slo-Pitch National or SPN, first started offering tournaments to Canada's slo-pitch community in 1989. SPN offers, to member teams, a Canada-wide qualifying tournament program leading to Regional, Provincial and National championships in over 22 category and calibre levels. Slo-Pitch National, along with a dedicated team of volunteers, administer, coordinate and regulate over 950 provincial qualifying tournaments each season across Canada.Submitted by admin on Fri, 02/03/2012 - 11:29About

Saving Lives Through Early Disease DiagnosisMiraculins is an emerging biotechnology company committed to extending life, reducing suffering and lowering healthcare costs. Through our leadership in the development and commercialization of diagnostic tests, we strive to improve the overall diagnosis and treatment of patients by enhancing the information available to physicians.The Miraculins AdvantageProducts & ProgramsMiraculins is dedicated to the development and commercialization of diagnostic tests and risk assessment technologies for diseases and conditions that are lacking highly sensitive and specific tests.

President & Chief Executive OfficerStuart OlsonMr. LeMay was appointed President & CEO effective June 1, 2013. Prior thereto David served as President & COO from July 2012 to May 31, 2013.Previously, David was President of Stuart Olson Industrial Group, which provides integrated products and services on behalf of the industrial sector for the company. Mr. LeMay has also served as President and COO of Stuart Olson's Laird Electric Inc. subsidiary.During his 25 years in the construction industry Mr. LeMay has been involved in all aspects of the field from estimating through to project management.David is a licensed construction electrician and has an MBA from Queens University.Daryl E. SandsDaryl E. Sands, B.Comm., CAExecutive Vice President & Chief Financial OfficerStuart OlsonMr. Sands joined Churchill as Chief Financial Officer in 2005.Previously Daryl was Partner & Senior Vice President, PriceWaterhouseCoopers, and prior thereto Vice President, PriceWaterhouseCoopers.Mr. Sands is a seasoned business executive with an extensive background in accounting, financial controls, management information systems and corporate finance.Evan T.JohnstonEvan T.

Our ProductsAGGRASTAT® - US GP IIb/IIIa inhibitor market - $400 million (AGGRASTAT® + two competitors)TARDOXALTM - in Phase II clinical development for the treatment of Tardive Dyskinesia - a large, unmet needAbout MedicureMedicure is a specialty pharmaceutical company engaged in the research, clinical development and commercialization of human therapeutics.HistoryMedicure founded in 1997 is a specialty pharmaceutical company engaged in the research, clinical development and commercialization of human therapeutics. Medicure has raised over $140 million and focused this investment on the advancement and clinical development of cardiovascular drugs. In 2006 Medicure acquired the USA commercial rights to AGGRASTAT (tirofiban HCl), a cardiovascular drug originally developed by Merck. AGGRASTAT, in combination with heparin, is indicated for the treatment of acute coronary syndrome. Medicurés business is generating revenue to support operations and to make selected investments in the clinical advancement of AGGRASTAT.TodayMedicurés core focus is on the US commercial sales of its FDA approved small molecule, AGGRASTAT.